Logo image of 1ANTM.MI

ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis

Europe - BIT:1ANTM - US0367521038 - Common Stock

304.2 EUR
+2.7 (+0.9%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

4

1ANTM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 31 industry peers in the Health Care Providers & Services industry. 1ANTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ANTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

1ANTM had positive earnings in the past year.
1ANTM had a positive operating cash flow in the past year.
In the past 5 years 1ANTM has always been profitable.
1ANTM had a positive operating cash flow in each of the past 5 years.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

1ANTM's Return On Assets of 4.40% is fine compared to the rest of the industry. 1ANTM outperforms 77.14% of its industry peers.
With a Return On Equity value of 12.26%, 1ANTM perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
1ANTM has a Return On Invested Capital (5.90%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 6.26%.
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROIC 5.9%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 2.83%, 1ANTM is in line with its industry, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ANTM has declined.
With a Operating Margin value of 4.60%, 1ANTM perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
1ANTM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.6%
PM (TTM) 2.83%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

1ANTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, 1ANTM has less shares outstanding
The number of shares outstanding for 1ANTM has been reduced compared to 5 years ago.
The debt/assets ratio for 1ANTM is higher compared to a year ago.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.70, 1ANTM is doing good in the industry, outperforming 71.43% of the companies in the same industry.
A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
1ANTM has a better Debt to Equity ratio (0.65) than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Altman-Z N/A
ROIC/WACC0.73
WACC8.12%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The earnings per share for 1ANTM have decreased by -6.64% in the last year.
Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
1ANTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
1ANTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%

3.2 Future

The Earnings Per Share is expected to grow by 7.89% on average over the next years.
The Revenue is expected to grow by 8.96% on average over the next years. This is quite good.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.76, the valuation of 1ANTM can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of 1ANTM indicates a rather cheap valuation: 1ANTM is cheaper than 82.86% of the companies listed in the same industry.
1ANTM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
1ANTM is valuated reasonably with a Price/Forward Earnings ratio of 11.27.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ANTM indicates a somewhat cheap valuation: 1ANTM is cheaper than 71.43% of the companies listed in the same industry.
1ANTM is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.76
Fwd PE 11.27
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1ANTM's Enterprise Value to EBITDA ratio is in line with the industry average.
1ANTM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.12
EV/EBITDA 9.95
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y-2.2%
EPS Next 3Y3%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.96%, 1ANTM has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.52, 1ANTM pays a bit more dividend than its industry peers.
1ANTM's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.96%

5.2 History

The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1ANTM pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

BIT:1ANTM (10/10/2025, 7:00:00 PM)

304.2

+2.7 (+0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap68.50B
Revenue(TTM)189.25B
Net Income(TTM)5.36B
Analysts76.43
Price Target317.97 (4.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.96%
Yearly Dividend5.61
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-24.27%
PT rev (3m)-34.19%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-42.5%
EPS NY rev (1m)-13.11%
EPS NY rev (3m)-12.64%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE 10.76
Fwd PE 11.27
P/S 0.42
P/FCF 15.12
P/OCF 12.48
P/B 1.83
P/tB 20.71
EV/EBITDA 9.95
EPS(TTM)28.27
EY9.29%
EPS(NY)27
Fwd EY8.87%
FCF(TTM)20.12
FCFY6.61%
OCF(TTM)24.37
OCFY8.01%
SpS719.51
BVpS166.22
TBVpS14.69
PEG (NY)N/A
PEG (5Y)0.96
Graham Number325.16
Profitability
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROCE 7.72%
ROIC 5.9%
ROICexc 6.38%
ROICexgc 11.77%
OM 4.6%
PM (TTM) 2.83%
GM N/A
FCFM 2.8%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Debt/EBITDA 2.8
Cap/Depr 75.47%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 62.96%
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.12%
ROIC/WACC0.73
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%